Induction chemotherapy plus PD-1 blockade and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: a propensity-matched retrospective study
Adding PD-1 inhibitor plus nimotuzumab to induction chemotherapy improved early tumor shrinkage while maintaining an acceptable safety profile. These encouraging early data reinforce the need for ongoing prospective trials to confirm long-term benefit and to refine patient selection.
Authors
- Zhongde Mu (ORCID: https://orcid.org/0000-0002-1984-4049)
- Lirong Wu
- Dan Zong
- Yiyue He
- Xia He (ORCID: https://orcid.org/0000-0002-8144-5372)
- Yichen Mao
Institutions
- Xuzhou Medical College (CN)
- Jiangsu Cancer Hospital (CN)
Publication Details
- Journal
- Japanese Journal of Clinical Oncology
- Published
- 2025-12-21
- DOI
- https://doi.org/10.1093/jjco/hyaf213
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00